OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

or maybe not :)

OXB seems to be showing impressive resistance to the general downtrend. I notice NTX is also in the same camp. It is often said that the shares with real potential do not fall as much when there is a sudden downward spike.

Yep, holding up surprisingly well on a day like this.

resisted the spike pretty well, without today reckon could have tested 30p

asm worth looking at. Brill news

American Society for Microbiology ?

The Orange County presentation is this afternoon, may be extremely exciting news which is possibly why sp holding up/ recovering soon after any profit taking.

Have topped up this morning - some major activity will push sp imho

Someones picking up shares - plenty of regular 100k buys over the last few days, If Pfizer are stakebuilding we should get an announcement soon. Personally I don't think a bid is in the shareholders interests but can see the attraction to any large pharma co. 40p - no way though! They won't get it that cheap.

When's the news expected of the liver cancer presentation, anyone know how important this is to OXB? and how big ARIUS are?

I suppose with good news around, it will fall back again as usual until the news sinks in & the price recovers again.

I bought into PLM this afternoon & I'm tempted to sell a few OXB to put more into PLM.

what does everyone think the share price could go too???if a buyout is close????

50p easily

Come on baby - 50p

I hope so but when?

The false dawns are very useful for trading though.

The product portfolio looks to be worth much more than 50p though.

agree, if Trovax works, then forget 50p, this co. will be worth a couple of billion so 4 +

Oxford Biomedica PLC
20 April 2005


Oxford BioMedica plc (the 'Company')

Notification of Major Interests in Shares

The Company has received notification today from UBS AG that on 18
April 2005 it, acting through its business and legal entities, had an interest
in 11,351,250 Oxford BioMedica plc 1p ordinary shares. This represents 3.03% of
the presently issued share capital of the Company, which stands at 374,315,769
shares.

What would be nice to see is it passing through the 30p mark. After that it will all the way up.

Some major interest this morning. I believe some very good news at the presentation in O.C is attracting the institutional investors coupled with bid spec is fuelling the sp. UBS Ag may also be increasing holding. Re a value on takeover, anyones guess depending on scientists analysis of what the Trials really mean in terms of possibility of cures and the commercial viability and what someone is prepared to pay for a potential blockbuster.

Hmmmmm, nearly 30p, will it actually go through it this time?